Patents by Inventor Judith Britz

Judith Britz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for monitoring the immune response and predicting clinical outcomes in transplant recipients
    Patent number: 7476514
    Abstract: Methods for monitoring the immune response and predicting clinical outcomes for patients on immunosuppressive drugs (such as transplant patients) are provided. The methods are based on the measurement of an intracellular metabolic marker in lymphocytes (such as ATP) as an indicator of a patient's immune response.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: January 13, 2009
    Assignee: Cylex, Inc.
    Inventors: Judith A. Britz, Peter R. Sottong, Richard J. Kowalski
  • Method for monitoring the immune response and predicting clinical outcomes in transplant recipients
    Publication number: 20030199006
    Abstract: Methods for monitoring the immune response and predicting clinical outcomes for patients on immunosuppressive drugs (such as transplant patients) are provided. The methods are based on the measurement of an intracellular metabolic marker in lymphocytes (such as ATP) as an indicator of a patient's immune response.
    Type: Application
    Filed: April 11, 2003
    Publication date: October 23, 2003
    Inventors: Judith A. Britz, Peter R. Sottong, Richard J. Kowalski
  • Target component assay utilizing specific gravity-altering liposomes
    Patent number: 5593848
    Abstract: An improved assay of target components in a sample utilizes specific gravity-altering particles which are attached to the target components by specific antibodies. The attached specific gravity-altering particles are preferably liposomes which will buoy or sink the targets to a common level in the specimen sample when the latter has been centrifuged in a transparent tube. The liposomes can provide an accentuated and more pronounced indication of the presence of the targets in the sample due to their ability to contain many multiples of fluorescent or non-fluorescent dye molecules with minimal steric interference with the attached antibodies' binding ability.
    Type: Grant
    Filed: November 7, 1994
    Date of Patent: January 14, 1997
    Assignee: Becton Dickinson and Company
    Inventors: Robert A. Levine, Stephen C. Wardlaw, Rodolfo Rodriguez, Judith Britz, Thomas J. Mercolino